Search Results - "Bruzzi, P."

Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies by Lambertini, M., Ceppi, M., Poggio, F., Peccatori, F.A., Azim, H.A., Ugolini, D., Pronzato, P., Loibl, S., Moore, H.C.F., Partridge, A.H., Bruzzi, P., Del Mastro, L.

“…The role of temporary ovarian suppression with luteinizing hormone-releasing hormone agonists (LHRHa) in the prevention of chemotherapy-induced premature…”
Get full text

Metformin plus chemotherapy versus chemotherapy alone in the first-line treatment of HER2-negative metastatic breast cancer. The MYME randomized, phase 2 clinical trial by Nanni, O., Amadori, D., De Censi, A., Rocca, A., Freschi, A., Bologna, A., Gianni, L., Rosetti, F., Amaducci, L., Cavanna, L., Foca, F., Sarti, S., Serra, P., Valmorri, L., Bruzzi, P., Corradengo, D., Gennari, A.

“…Purpose To investigate the efficacy of metformin (M) plus chemotherapy versus chemotherapy alone in metastatic breast cancer (MBC). Methods Non-diabetic women…”
Get full text

Endocrine and metabolic complications in children and adolescents with Sickle Cell Disease: an Italian cohort study by Mandese, V, Bigi, E, Bruzzi, P, Palazzi, G, Predieri, B, Lucaccioni, L, Cellini, M, Iughetti, L

“…Children with Sickle Cell Disease (SCD) show endocrine complications and metabolic alterations. The physiopathology of these conditions is not completely…”
Get full text

Surrogate endpoints for EDSS worsening in multiple sclerosis: A meta-analytic approach by SORMANI, M. P, BONZANO, L, ROCCATAGLIATA, L, MANCARDI, G. L, UCCELLI, A, BRUZZI, P

“…To evaluate whether the effects on potential surrogate endpoints, such as MRI markers and relapses, observed in trials of experimental treatments are able to…”
Get full text

Role of micronucleus test in predicting breast cancer susceptibility: a systematic review and meta-analysis by Cardinale, F, Bruzzi, P, Bolognesi, C

“…Background: The cytokinesis-block micronucleus test (MNT), as a marker of chromosomal mutagen sensitivity, was applied in a number of studies enrolling breast…”
Get full text

Sentinel node biopsy compared with complete axillary dissection for staging early breast cancer with clinically negative lymph nodes: results of randomized trial by Canavese, G., Catturich, A., Vecchio, C., Tomei, D., Gipponi, M., Villa, G., Carli, F., Bruzzi, P., Dozin, B.

“…Background: Sentinel lymph node (SLN) staging is currently used to avoid complete axillary dissection in breast cancer patients with negative SLNs. Evidence of…”
Get full text

Combined MRI lesions and relapses as a surrogate for disability in multiple sclerosis by SORMANI, M. P, LI, D. K, BRUZZI, P, STUBINSKI, B, CORNELISSE, P, ROCAK, S, DE STEFANO, N

“…In multiple sclerosis (MS), the aim of therapies is to prevent the accumulation of irreversible disability. This is difficult to assess given the short time…”
Get full text

Mortality after bloodstream infections in allogeneic haematopoietic stem cell transplant (HSCT) recipients by Mikulska, M., Del Bono, V., Bruzzi, P., Raiola, A. M., Gualandi, F., Van Lint, M. T., Bacigalupo, A., Viscoli, C.

“…Purpose Bloodstream infections (BSIs) are frequent after allogeneic haematopoietic stem cell transplantation (HSCT). The aim of this study was to identify…”
Get full text

Rare Cancers Europe (RCE) methodological recommendations for clinical studies in rare cancers: a European consensus position paper by Casali, P.G., Bruzzi, P., Bogaerts, J., Blay, J.-Y., Aapro, M., Adamous, A., Berruti, A., Blay, J.-Y., Bogaerts, J., Bressington, J., Bruzzi, B., Capocaccia, R., Cardoso, F., Casali, P.G., Celis, J.E., Cervantes, A., Ciardiello, F., Claussen, C., Coleman, M., Comis, S., Craine, S., De Boltz, D., De Lorenzo, F., Dei Tos, A.P., Gatta, G., Geissler, J., Giuliani, R., Grande, E., Gronchi, A., Jezdic, S., Jonsson, B., Jost, L., Keulen, H., Lacombe, D., Lamory, G., Le Cam, Y., Leto di Priolo, S., Licitra, L., Macchia, F., Margulies, A., Marreaud, S., McVie, G., Narbutas, S., Oliver, K., Pavlidis, N., Pelouchova, J., Pentheroudakis, G., Piccart, M., Pierotti, M.A., Pravettoni, G., Redmond, K., Riegman, P., Ruffilli, M.P., Ryner, D., Sandrucci, S., Seymour, M., Torri, V., Trama, A., Van Belle, S., Vassal, G., Wartenberg, M., Watts, C., Wilson, A., Yared, W.

“…While they account for one-fifth of new cancer cases, rare cancers are difficult to study. A higher than average degree of uncertainty should be accommodated…”
Get full text

Previous bloodstream infections due to other pathogens as predictors of carbapenem-resistant Klebsiella pneumoniae bacteraemia in colonized patients: results from a retrospective multicentre study by Giacobbe, D. R., Del Bono, V., Bruzzi, P., Corcione, S., Giannella, M., Marchese, A., Magnasco, L., Maraolo, A. E., Pagani, N., Saffioti, C., Ambretti, S., Cardellino, C. S., Coppo, E., De Rosa, F. G., Viale, P., Viscoli, C.

“…Introduction: the purpose of this retrospective multicenter study was to assess whether the risk of developing bloodstream infections (BSI) due to…”
Get full text

Difficulties in conducting pure academic research, obstacles in data collection and quality of informations: The example of the INTERCEPTOR study by Merlano, M, Denaro, N, Benasso, M, Licitra, L, Bossi, P, Locati, L, Vecchio, S, Bruzzi, P

“…Highlights•Interceptor trial compared concurrent chemoradiotherapy with induction chemotherapy followed by Cetuximab RT. We reported difficulty in data…”
Get full text

Breast cancer incidence trends in European women aged 20–39 years at diagnosis by Merlo, D. F., Ceppi, M., Filiberti, R., Bocchini, V., Znaor, A., Gamulin, M., Primic-Žakelj, M., Bruzzi, P., Bouchardy, C., Fucic, A.

“…An increase in the incidence of breast cancer in women aged <40 years has been reported in recent years. Increased incidence could be partly explained by…”
Get full text

Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience by Mancardi, GL, Sormani, MP, Di Gioia, M, Vuolo, L, Gualandi, F, Amato, MP, Capello, E, Currò, D, Uccelli, A, Bertolotto, A, Gasperini, C, Lugaresi, A, Merelli, E, Meucci, G, Motti, L, Tola, MR, Scarpini, E, Repice, AM, Massacesi, L, Saccardi, R, Donnini, I, Bosi, A, Guidi, S, Bagigalupo, A, Bonzano, L, Bruzzi, P, Roccatagliata, L, Antenucci, R, Granella, F, Martino, G, Rottoli, M, Solaro, C, Salvi, F, Barilaro, A, Capobianco, M

“…Background: Over recent years numerous patients with severe forms of multiple sclerosis (MS) refractory to conventional therapies have been treated with…”
Get full text

Initial serum (1,3)-β-d-glucan as a predictor of mortality in proven candidaemia: findings from a retrospective study in two teaching hospitals in Italy and Brazil by Giacobbe, D.R., Esteves, P., Bruzzi, P., Mikulska, M., Furfaro, E., Mesini, A., Tatarelli, P., Grignolo, S., Viscoli, C., Colombo, A.L., Del Bono, V.

“…A retrospective study was conducted to assess the role of initial serum (1,3)-β-d-glucan (BDG) values in predicting mortality in proven candidaemia. The study…”
Get full text

Treatment of localised resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma Group by De Bernardi, B, Mosseri, V, Rubie, H, Castel, V, Foot, A, Ladenstein, R, Laureys, G, Beck-Popovic, M, de Lacerda, A F, Pearson, A D J, De Kraker, J, Ambros, P F, de Rycke, Y, Conte, M, Bruzzi, P, Michon, J

“…Main objective of this study was to confirm that surgery alone is an effective and safe treatment for localised resectable neuroblastoma except stage 2 with…”
Get full text

Concurrent versus sequential adjuvant chemo-endocrine therapy in hormone-receptor positive early stage breast cancer patients: a systematic review and meta-analysis by Poggio, F, Ceppi, M, Lambertini, M, Bruzzi, P, Ugolini, D, Bighin, C, Levaggi, A, Giraudi, S, D'Alonzo, A, Vaglica, M, Blondeaux, E, Sertoli, M.R, Pronzato, P, Del Mastro, L., MD

“…Abstract Background Although in clinical practice adjuvant chemotherapy (CT) and endocrine therapy (ET) are administered sequentially in patients with…”
Get full text

Diagnosis and prognosis disclosure among cancer patients. Results from an Italian mortality follow-back survey by Costantini, M., Morasso, G., Montella, M., Borgia, P., Cecioni, R., Beccaro, M., Sguazzotti, E., Bruzzi, P.

“…Background: The observed cultural changes in truth-telling attitudes suggest a radical change in the practice of delivering information to cancer patients, but…”
Get full text

210 Genetic and epigenetic factors affect RET gene expression in breast cancer cell lines and influence survival in patients by Griseri, P, Garrone, O, Lo Sardo, A, Monteverde, M, Rusmini, M, Tonissi, F, Merlano, M, Bruzzi, P, Ceccherini, I, Nigro, C. Lo

Get full text

International Expert Consensus on Primary Systemic Therapy in the Management of Early Breast Cancer: Highlights of the Fourth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2010) by Berruti, Alfredo, Generali, Daniele, Kaufmann, Manfred, Puztai, Lajos, Curigliano, Giuseppe, Aglietta, Massimo, Gianni, Luca, Miller, William R., Untch, Michael, Sotiriou, Christos, Daidone, Mariagrazia, Conte, PierFranco, Kennedy, Derek, Damia, Giovanna, Petronini, Piergiorgio, Di Cosimo, Serena, Bruzzi, Paolo, Dowsett, Mitch, Desmedt, Christine, Mansel, Robert E., Olivetti, Lucio, Tondini, Carlo, Sapino, Anna, Fenaroli, Privato, Tortora, Gianpaolo, Thorne, Hather, Bertolini, Francesco, Ferrozzi, Francesco, Danova, Marco, Tagliabue, Elda, de Azambuja, Evandro, Makris, Andreas, Tampellini, Marco, Dontu, Gabriela, Van't Veer, Laura, Harris, Adrian L., Fox, Stephen B., Dogliotti, Luigi, Bottini, Alberto

“…A panel of international breast cancer experts formulated a declaration of consensus regarding many key issues in the use of primary systemic therapy (PST)…”
Get full text

A risk score model predictive of the presence of additional disease in the axilla in early-breast cancer patients with one or two metastatic sentinel lymph nodes by Canavese, G, Bruzzi, P, Catturich, A, Vecchio, C, Tomei, D, Del Mastro, L, Carli, F, Guenzi, M, Lacopo, F, Dozin, B

“…Abstract Background Axillary lymph node dissection (ALND) in early-breast cancer patients with positive sentinel node (SLN+) may not always be necessary. Aims…”
Get full text